Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
出版年份 2022 全文链接
标题
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
作者
关键词
-
出版物
DIABETOLOGIA
Volume 65, Issue 12, Pages 1925-1966
出版商
Springer Science and Business Media LLC
发表日期
2022-09-24
DOI
10.1007/s00125-022-05787-2
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- 2022 National Standards for Diabetes Self-Management Education and Support
- (2022) Jody Davis et al. DIABETES CARE
- Primary Prevention of Cardiovascular and Heart Failure Events With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Their Combination in Type 2 Diabetes
- (2022) Alison K. Wright et al. DIABETES CARE
- Effects of empagliflozin on markers of liver steatosis and fibrosis and their relationship to cardiorenal outcomes
- (2022) Sabine Kahl et al. DIABETES OBESITY & METABOLISM
- Cardiovascular and Renal Outcomes with Canagliflozin in Patients with Peripheral Artery Disease: Data from the CANVAS program and CREDENCE trials
- (2022) Jennifer Y Barraclough et al. DIABETES OBESITY & METABOLISM
- Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes
- (2022) Dominik Dahl et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Exercise/Physical Activity in Individuals with Type 2 Diabetes: A Consensus Statement from the American College of Sports Medicine
- (2022) JILL A. KANALEY et al. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE
- Effect of Sleep Extension on Objectively Assessed Energy Intake Among Adults With Overweight in Real-life Settings
- (2022) Esra Tasali et al. JAMA Internal Medicine
- Association of Sodium-Glucose Cotransporter 2 Inhibitors With Cardiovascular Outcomes in Patients With Type 2 Diabetes and Other Risk Factors for Cardiovascular Disease
- (2022) Mukul Bhattarai et al. JAMA Network Open
- Semaglutide reduces cardiovascular events regardless of metformin use: a post hoc subgroup analysis of SUSTAIN 6 and PIONEER 6
- (2022) Mansoor Husain et al. Cardiovascular Diabetology
- Social Determinants of Health, Race, and Diabetes Population Health Improvement: Black/African Americans as a Population Exemplar
- (2022) Felicia Hill-Briggs et al. Current Diabetes Reports
- Effects of Intensive Lifestyle Intervention on All-Cause Mortality in Older Adults With Type 2 Diabetes and Overweight/Obesity: Results From the Look AHEAD Study
- (2022) et al. DIABETES CARE
- Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis
- (2022) Thomas Karagiannis et al. DIABETOLOGIA
- Tirzepatide cardiovascular event risk assessment: a pre-specified meta-analysis
- (2022) Naveed Sattar et al. NATURE MEDICINE
- Ertugliflozin and incident obstructive sleep apnea: an analysis from the VERTIS CV trial
- (2022) Brian S. Wojeck et al. Sleep and Breathing
- Effects of sleep manipulation on markers of insulin sensitivity: A systematic review and meta-analysis of randomized controlled trials
- (2022) Nina Sondrup et al. SLEEP MEDICINE REVIEWS
- Dose-Dependent Effect of Supervised Aerobic Exercise on HbA1c in Patients with Type 2 Diabetes: A Meta-analysis of Randomized Controlled Trials
- (2022) Ahmad Jayedi et al. SPORTS MEDICINE
- Effects of Semaglutide on Stroke Subtypes in Type 2 Diabetes: Post Hoc Analysis of the Randomized SUSTAIN 6 and PIONEER 6
- (2022) W. David Strain et al. STROKE
- Association of Glucagon-Like Peptide-1 Receptor Agonist Use With Risk of Gallbladder and Biliary Diseases
- (2022) Liyun He et al. JAMA Internal Medicine
- Effect of tirzepatide versus insulin degludec on liver fat content and abdominal adipose tissue in people with type 2 diabetes (SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial
- (2022) Amalia Gastaldelli et al. Lancet Diabetes & Endocrinology
- Comparison of Glycemic Variability and Hypoglycemic Events in Hospitalized Older Adults Treated with Basal Insulin plus Vildagliptin and Basal–Bolus Insulin Regimen: A Prospective Randomized Study
- (2022) Sol Batule et al. Journal of Clinical Medicine
- Intensive glycemic control and macrovascular, microvascular, hypoglycemia complications and mortality in older (age ≥60years) or frail adults with type 2 diabetes: a systematic review and meta-analysis from randomized controlled trial and observation studies
- (2022) Thomas Crabtree et al. Expert Review of Endocrinology & Metabolism
- Manufacturing with pluripotent stem cells ( PSConf 2021): Key issues for future research and development
- (2022) Glyn N. Stacey et al. CELL PROLIFERATION
- Tirzepatide Once Weekly for the Treatment of Obesity
- (2022) Ania M. Jastreboff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Molecular characterisation of Acinetobacter baumannii isolates from bloodstream infections in a tertiary-level hospital in South Africa
- (2022) Michelle Lowe et al. Frontiers in Microbiology
- Polydatin activates the Nrf2/HO-1 signaling pathway to protect cisplatin-induced hearing loss in guinea pigs
- (2022) Dafei Li et al. Frontiers in Pharmacology
- Glycemia Reduction in Type 2 Diabetes — Microvascular and Cardiovascular Outcomes
- (2022) NEW ENGLAND JOURNAL OF MEDICINE
- Glycemia Reduction in Type 2 Diabetes — Glycemic Outcomes
- (2022) NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Dulaglutide 3.0 mg and 4.5 mg Versus Dulaglutide 1.5 mg in Metformin-Treated Patients With Type 2 Diabetes in a Randomized Controlled Trial (AWARD-11)
- (2021) Juan P. Frias et al. DIABETES CARE
- A global perspective on the issue of access to insulin
- (2021) David Beran et al. DIABETOLOGIA
- The role of GLP-1 in the postprandial effects of acarbose in type 2 diabetes
- (2021) Niels B Dalsgaard et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial
- (2021) Geltrude Mingrone et al. LANCET
- Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials
- (2021) Suetonia C Palmer et al. BMJ-British Medical Journal
- Cardiovascular, Renal, and Metabolic Outcomes of Dapagliflozin Versus Placebo in a Primary Cardiovascular Prevention Cohort: Analyses From DECLARE-TIMI 58
- (2021) Avivit Cahn et al. DIABETES CARE
- SGLT ‐2 inhibitors for prevention of cardiorenal outcomes in type 2 diabetes: an updated meta‐analysis.
- (2021) Dario Giugliano et al. DIABETES OBESITY & METABOLISM
- GLP-1 receptor agonists and SGLT2 inhibitors for older people with type 2 diabetes: A systematic review and meta-analysis
- (2021) Thomas Karagiannis et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial
- (2021) Melanie Davies et al. LANCET
- Once-Weekly Semaglutide in Adults with Overweight or Obesity
- (2021) John P.H. Wilding et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Novel User Utility Score for Diabetes Management Using Tailored Mobile Coaching: Secondary Analysis of a Randomized Controlled Trial
- (2021) Min-Kyung Lee et al. JMIR mHealth and uHealth
- Frequency of Interruptions to Sitting Time: Benefits for Postprandial Metabolism in Type 2 Diabetes
- (2021) Ashleigh R. Homer et al. DIABETES CARE
- Real-world clinical outcomes and costs in type 2 diabetes mellitus patients after initiation of insulin therapy: A German claims data analysis
- (2021) Maximilian Gabler et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity
- (2021) Domenica Rubino et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Does Lifestyle Intervention Improve Health of Adults with Overweight/Obesity and Type 2 Diabetes: Findings from the Look AHEAD Randomized Trial
- (2021) Rena R. Wing et al. Obesity
- Patient-reported Outcomes After Metabolic Surgery Versus Medical Therapy for Diabetes
- (2021) Ali Aminian et al. ANNALS OF SURGERY
- The Impact of Frailty on the Effectiveness and Safety of Intensive Glucose Control and Blood Pressure–Lowering Therapy for People With Type 2 Diabetes: Results From the ADVANCE Trial
- (2021) Tu N. Nguyen et al. DIABETES CARE
- Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes
- (2021) Matthew C. Riddle et al. DIABETES CARE
- Historical HbA1c Values May Explain the Type 2 Diabetes Legacy Effect: UKPDS 88
- (2021) Marcus Lind et al. DIABETES CARE
- Comparative efficacy of glucose‐lowering medications on body weight and blood pressure in patients with type 2 diabetes: A systematic review and network meta‐analysis
- (2021) Apostolos Tsapas et al. DIABETES OBESITY & METABOLISM
- GLP-1 receptor agonists for cardiovascular outcomes with and without metformin. A systematic review and meta-analysis of cardiovascular outcomes trials
- (2021) Apostolos Tsapas et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Intermittent fasting versus continuous energy-restricted diet for patients with type 2 diabetes mellitus and metabolic syndrome for glycemic control: A systematic review and meta-analysis of randomized controlled trials
- (2021) Xue Wang et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Pioglitazone even at low dosage improves NAFLD in type 2 diabetes: clinical and pathophysiological insights from a subgroup of the TOSCA.IT randomised trial
- (2021) Giuseppe Della Pepa et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- The efficacy and safety of novel classes of glucose-lowering drugs for cardiovascular outcomes: a network meta-analysis of randomised clinical trials
- (2021) Donna Shu-Han Lin et al. DIABETOLOGIA
- Sleep disorders in people with type 2 diabetes and associated health outcomes: a review of the literature
- (2021) Samantha B. J. Schipper et al. DIABETOLOGIA
- Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease
- (2021) Fasiha Kanwal et al. GASTROENTEROLOGY
- Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin
- (2021) Thomas Martens et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial
- (2021) Julio Rosenstock et al. LANCET
- Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial
- (2021) Bernhard Ludvik et al. LANCET
- Advancing the Learning Health System
- (2021) J. Michael McGinnis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes
- (2021) Juan P. Frías et al. NEW ENGLAND JOURNAL OF MEDICINE
- Empagliflozin in Heart Failure with a Preserved Ejection Fraction
- (2021) Stefan D. Anker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes
- (2021) Hertzel C. Gerstein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-Term Complications in Youth-Onset Type 2 Diabetes
- (2021) NEW ENGLAND JOURNAL OF MEDICINE
- Long‐term health benefits of intensive lifestyle intervention in the Look AHEAD study
- (2021) W. Timothy Garvey Obesity
- Network Meta-Analysis of Metabolic Surgery Procedures for the Treatment of Obesity and Diabetes
- (2021) Andrew C. Currie et al. OBESITY SURGERY
- Effects of SGLT2 inhibitors on stroke and its subtypes in patients with type 2 diabetes: a systematic review and meta-analysis
- (2021) Wen-Hsuan Tsai et al. Scientific Reports
- Efficacy and safety of once-weekly semaglutide 2·0 mg versus 1·0 mg in patients with type 2 diabetes (SUSTAIN FORTE): a double-blind, randomised, phase 3B trial
- (2021) Juan P Frías et al. Lancet Diabetes & Endocrinology
- Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2021) Mikhail N Kosiborod et al. Lancet Diabetes & Endocrinology
- Rationality, Efficacy, Tolerability of Empagliflozin plus Linagliptin Combination for the Management of Type 2 Diabetes Mellitus: A Systematic review of randomized controlled trials and observational studies.
- (2021) Santenna Chenchul et al. CURRENT DIABETES REVIEWS
- Canagliflozin and Kidney-Related Adverse Events in Type 2 Diabetes and CKD: Findings From the Randomized CREDENCE Trial
- (2021) Hiddo J.L. Heerspink et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Sodium–Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists and the Risk for Cardiovascular Outcomes in Routine Care Patients With Diabetes Across Categories of Cardiovascular Disease
- (2021) Elisabetta Patorno et al. ANNALS OF INTERNAL MEDICINE
- Efpeglenatide and Clinical Outcomes With and Without Concomitant Sodium-Glucose Cotransporter-2 Inhibition Use in Type 2 Diabetes: Exploratory Analysis of the AMPLITUDE-O Trial
- (2021) Carolyn S.P. Lam et al. CIRCULATION
- Effect of the Glucagon-Like Peptide-1 Receptor Agonists Semaglutide and Liraglutide on Kidney Outcomes in Patients With Type 2 Diabetes: Pooled Analysis of SUSTAIN 6 and LEADER
- (2021) Ahmed M. Shaman et al. CIRCULATION
- 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2022
- (2021) DIABETES CARE
- 6. Glycemic Targets: Standards of Medical Care in Diabetes—2022
- (2021) DIABETES CARE
- 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes—2022
- (2021) DIABETES CARE
- 10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2022
- (2021) DIABETES CARE
- Introduction: Standards of Medical Care in Diabetes—2022
- (2021) DIABETES CARE
- 1. Improving Care and Promoting Health in Populations: Standards of Medical Care in Diabetes—2022
- (2021) DIABETES CARE
- 7. Diabetes Technology: Standards of Medical Care in Diabetes—2022
- (2021) DIABETES CARE
- 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2022
- (2021) DIABETES CARE
- 5. Facilitating Behavior Change and Well-being to Improve Health Outcomes: Standards of Medical Care in Diabetes—2022
- (2021) DIABETES CARE
- 8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Medical Care in Diabetes—2022
- (2021) DIABETES CARE
- IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045
- (2021) Hong Sun et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Prevalence of type 2 diabetes in psychiatric disorders: an umbrella review with meta-analysis of 245 observational studies from 32 systematic reviews
- (2021) Nanna Lindekilde et al. DIABETOLOGIA
- Validation of the classification for type 2 diabetes into five subgroups: a report from the ORIGIN trial
- (2021) Marie Pigeyre et al. DIABETOLOGIA
- Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial
- (2021) Stefano Del Prato et al. LANCET
- Obesity management as a primary treatment goal for type 2 diabetes: time to reframe the conversation
- (2021) Ildiko Lingvay et al. LANCET
- Insulin discovery: A pivotal point in medical history
- (2021) Pierpaolo Falcetta et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Subcutaneous infusion of exenatide and cardiovascular outcomes in type 2 diabetes: a non-inferiority randomized controlled trial
- (2021) Christian T. Ruff et al. NATURE MEDICINE
- Advancing the global public health agenda for NAFLD: a consensus statement
- (2021) Jeffrey V. Lazarus et al. Nature Reviews Gastroenterology & Hepatology
- Comparative Effectiveness of Bariatric Surgeries in Patients with Type 2 Diabetes Mellitus and BMI ≥ 25 kg/m2: a Systematic Review and Network Meta-Analysis
- (2021) Maria Neves Carmona et al. OBESITY SURGERY
- Efficacy and safety of the addition of sitagliptin to treatment of youth with type 2 diabetes and inadequate glycemic control on metformin without or with insulin
- (2021) Muhammad Yazid Jalaludin et al. PEDIATRIC DIABETES
- Managing the gastrointestinal side effects of GLP-1 receptor agonists in obesity: recommendations for clinical practice
- (2021) Sean Wharton et al. POSTGRADUATE MEDICINE
- Reappraisal of the efficacy of intensive glycaemic control on microvascular complications in patients with type 2 diabetes: A meta-analysis of randomised control-trials
- (2021) Sophie Sun et al. THERAPIE
- A meta-analysis of the effects of glucagon-like-peptide 1 receptor agonist (GLP1-RA) in nonalcoholic fatty liver disease (NAFLD) with type 2 diabetes (T2D)
- (2021) Samit Ghosal et al. Scientific Reports
- Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials
- (2021) Naveed Sattar et al. Lancet Diabetes & Endocrinology
- Diabetes mellitus correlates with increased biological age as indicated by clinical biomarkers
- (2021) Nadine Bahour et al. GeroScience
- Cardiovascular and mortality outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: A meta-analysis with the FREEDOM cardiovascular outcomes trial
- (2021) Matthew M.Y. Lee et al. Diabetes & Metabolic Syndrome-Clinical Research & Reviews
- Changes in dietary intake improve glycemic control following a structured nutrition therapy during Ramadan in individuals with type 2 diabetes
- (2021) Barakatun-Nisak Mohd Yusof et al. Clinical Nutrition ESPEN
- Glucagon-like Peptide-1 Receptor Agonists and Cardioprotective Benefit in Patients with Type 2 Diabetes Without Baseline Metformin: A Systematic Review and Update Meta-analysis
- (2021) Augusto Lavalle-Cobo et al. High Blood Pressure & Cardiovascular Prevention
- The Effectiveness of Telemedicine Solutions for the Management of Type 2 Diabetes: A Systematic Review, Meta-Analysis, and Meta-Regression
- (2021) Stine Hangaard et al. Journal of diabetes science and technology
- Effect of high-intensity interval training protocols on VO2max and HbA1c level in people with type 2 diabetes: A systematic review and meta-analysis
- (2021) Mariana Brondani de Mello et al. Annals of Physical and Rehabilitation Medicine
- Efficacy and safety of anti-hyperglycaemic drugs in patients with non-alcoholic fatty liver disease with or without diabetes: An updated systematic review of randomized controlled trials
- (2020) A. Mantovani et al. DIABETES & METABOLISM
- Fixed‐dose combination of empagliflozin and linagliptin for the treatment of patients with type 2 diabetes mellitus: A systematic review and meta‐analysis
- (2020) Niki Katsiki et al. DIABETES OBESITY & METABOLISM
- Effects of Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide on Biomarkers of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes
- (2020) Mark L. Hartman et al. DIABETES CARE
- Sex Disparities in Cardiovascular Outcome Trials of Populations With Diabetes: A Systematic Review and Meta-analysis
- (2020) Kristin K. Clemens et al. DIABETES CARE
- Effects of Linagliptin on Cardiovascular and Kidney Outcomes in People With Normal and Reduced Kidney Function: Secondary Analysis of the CARMELINA Randomized Trial
- (2020) Vlado Perkovic et al. DIABETES CARE
- Metabolic surgery for the treatment of type 2 diabetes: A network meta‐analysis of randomized controlled trials
- (2020) Barbara Cresci et al. DIABETES OBESITY & METABOLISM
- Association of Daily Step Count and Step Intensity With Mortality Among US Adults
- (2020) Pedro F. Saint-Maurice et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Comparison of Structured Nutrition Therapy for Ramadan with Standard Care in Type 2 Diabetes Patients
- (2020) Barakatun-Nisak Mohd Yusof et al. Nutrients
- Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes
- (2020) Apostolos Tsapas et al. ANNALS OF INTERNAL MEDICINE
- Development of the Instrument to assess the Credibility of Effect Modification Analyses (ICEMAN) in randomized controlled trials and meta-analyses
- (2020) Stefan Schandelmaier et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Sleep Regularity and Cardiometabolic Heath: Is Variability in Sleep Patterns a Risk Factor for Excess Adiposity and Glycemic Dysregulation?
- (2020) Faris M. Zuraikat et al. Current Diabetes Reports
- Effects of Liraglutide on Cardiovascular Outcomes in Type 2 Diabetes Patients With and Without Baseline Metformin Use: Post Hoc Analyses of the LEADER Trial
- (2020) Matthew J. Crowley et al. DIABETES CARE
- Diabetes Self-management Education and Support in Adults With Type 2 Diabetes: A Consensus Report of the American Diabetes Association, the Association of Diabetes Care & Education Specialists, the Academy of Nutrition and Dietetics, the American Academy of Family Physicians, the American Academy of PAs, the American Association of Nurse Practitioners, and the American Pharmacists Association
- (2020) Margaret A. Powers et al. DIABETES CARE
- Glucagon‐like peptide‐1 receptor agonists and sodium‐glucose co‐transporter‐2 inhibitors as combination therapy for type 2 diabetes: A systematic review and meta‐analysis
- (2020) Chrysanthi Mantsiou et al. DIABETES OBESITY & METABOLISM
- Adults with early-onset type 2 diabetes (aged 18–39 years) are severely underrepresented in diabetes clinical research trials
- (2020) Jack A. Sargeant et al. DIABETOLOGIA
- Bariatric Surgery Provides Long-term Resolution of Nonalcoholic Steatohepatitis and Regression of Fibrosis
- (2020) Guillaume Lassailly et al. GASTROENTEROLOGY
- Association between combined treatment with SGLT2 inhibitors and metformin for type 2 diabetes mellitus on fracture risk: a meta-analysis of randomized controlled trials
- (2020) B-B. Qian et al. OSTEOPOROSIS INTERNATIONAL
- Type 2 diabetes and cognitive dysfunction—towards effective management of both comorbidities
- (2020) Velandai Srikanth et al. Lancet Diabetes & Endocrinology
- Physical behaviors and chronotype in people with type 2 diabetes
- (2020) Joseph Henson et al. BMJ Open Diabetes Research & Care
- Wrist-worn accelerometers: recommending ~1.0 mg as the minimum clinically important difference (MCID) in daily average acceleration for inactive adults
- (2020) Alex Rowlands et al. BRITISH JOURNAL OF SPORTS MEDICINE
- Early combination therapy delayed treatment escalation in newly diagnosed young‐onset type 2 diabetes: A subanalysis of the VERIFY study
- (2020) Juliana C. N. Chan et al. DIABETES OBESITY & METABOLISM
- SGLT2 inhibitors with and without metformin: a meta‐analysis of cardiovascular, kidney and mortality outcomes
- (2020) Brendon L Neuen et al. DIABETES OBESITY & METABOLISM
- Comparison of Glycemic Excursion Using Flash Continuous Glucose Monitoring in Patients with Type 2 Diabetes Mellitus Before and After Treatment with Voglibose
- (2020) Selvam Kasthuri et al. Diabetes Technology & Therapeutics
- Effects of sodium‐glucose co‐transporter 2 inhibitors on liver parameters and steatosis: A meta‐analysis of randomized clinical trials
- (2020) Francisca dos Santos Coelho et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Device‐measured physical activity and its association with physical function in adults with type 2 diabetes mellitus
- (2020) M. Mickute et al. DIABETIC MEDICINE
- Web-Based Interventions for Dietary Behavior in Adults With Type 2 Diabetes: Systematic Review of Randomized Controlled Trials
- (2020) Jedha Dening et al. JOURNAL OF MEDICAL INTERNET RESEARCH
- Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
- (2020) Milton Packer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dapagliflozin in Patients with Chronic Kidney Disease
- (2020) Hiddo J.L. Heerspink et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes
- (2020) Christopher P. Cannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art
- (2020) Michael A. Nauck et al. Molecular Metabolism
- Insights from VERIFY: Early Combination Therapy Provides Better Glycaemic Durability Than a Stepwise Approach in Newly Diagnosed Type 2 Diabetes
- (2020) David Matthews et al. Diabetes Therapy
- Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes
- (2020) Darren K. McGuire et al. JAMA Cardiology
- World Health Organization 2020 guidelines on physical activity and sedentary behaviour
- (2020) Fiona C Bull et al. BRITISH JOURNAL OF SPORTS MEDICINE
- Risk of Cardiovascular Outcomes in Type 2 Diabetes Patients Following Addition of SGLT2 Inhibitors Versus Sulfonylureas to Baseline GLP-IRA Therapy
- (2020) Chintan V. Dave et al. CIRCULATION
- Durability of Triple Combination Therapy Versus Stepwise Addition Therapy in Patients With New-Onset T2DM: 3-Year Follow-up of EDICT
- (2020) Muhammad Abdul-Ghani et al. DIABETES CARE
- 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes—2021
- (2020) DIABETES CARE
- HbA1c Change and Diabetic Retinopathy During GLP-1 Receptor Agonist Cardiovascular Outcome Trials: A Meta-analysis and Meta-regression
- (2020) M. Angelyn Bethel et al. DIABETES CARE
- Pioglitazone and bariatric surgery are the most effective treatments for non‐alcoholic steatohepatitis: A hierarchical network meta‐analysis
- (2020) Simona Panunzi et al. DIABETES OBESITY & METABOLISM
- Systematic review of clinical practice guidelines to identify recommendations for sleep in type 2 diabetes mellitus management
- (2020) Aisling Smyth et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Use of MyDesmond digital education programme to support self‐management in people with type 2 diabetes during the COVID‐19 pandemic
- (2020) Lauren M. Quinn et al. DIABETIC MEDICINE
- Insulin Resistance Is Central to Long-Term Reversal of Histologic Nonalcoholic Steatohepatitis After Metabolic Surgery
- (2020) Maria Francesca Russo et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Digital Coaching Strategies to Facilitate Behavioral Change in Type 2 Diabetes: A Systematic Review
- (2020) Bradley D Gershkowitz et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Lancet Commission on diabetes: using data to transform diabetes care and patient lives
- (2020) Juliana C N Chan et al. LANCET
- Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease
- (2020) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure
- (2020) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Barriers, facilitators, and interventions for medication adherence across chronic conditions with the highest non-adherence rates: a scoping review with recommendations for intervention development
- (2020) Pinelopi Konstantinou et al. Translational Behavioral Medicine
- SGLT2 inhibitors in patients with type 2 diabetes with non-alcoholic fatty liver diseases: an umbrella review of systematic reviews
- (2020) Shih-Chieh Shao et al. BMJ Open Diabetes Research & Care
- Effect of Telemetric Interventions on Glycated Hemoglobin A1c and Management of Type 2 Diabetes Mellitus: Systematic Meta-Review
- (2020) Claudia Eberle et al. JOURNAL OF MEDICAL INTERNET RESEARCH
- A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis
- (2020) Philip N. Newsome et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Next Generation of Diabetes Translation: A Path to Health Equity
- (2019) Debra Haire-Joshu et al. Annual Review of Public Health
- Does Metabolic Surgery Lead to Diabetes Remission in Patients with BMI
- (2019) Matilde Rubio-Almanza et al. OBESITY SURGERY
- Combination Therapy with an SGLT2 Inhibitor as Initial Treatment for Type 2 Diabetes: A Systematic Review and Meta-Analysis
- (2019) Tamara Milder et al. Journal of Clinical Medicine
- Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial
- (2019) Michael E J Lean et al. Lancet Diabetes & Endocrinology
- Pioglitazone Therapy in Patients With Stroke and Prediabetes
- (2019) J. David Spence et al. JAMA Neurology
- Dietary Patterns and Management Of Type 2 Diabetes: A Systematic Review Of Randomised Clinical Trials
- (2019) Dimitra Papamichou et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- The effect of intermittent compared with continuous energy restriction on glycaemic control in patients with type 2 diabetes: 24-month follow-up of a randomised noninferiority trial
- (2019) S. Carter et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Pioglitazone: The forgotten, cost-effective cardioprotective drug for type 2 diabetes
- (2019) Ralph A DeFronzo et al. Diabetes & Vascular Disease Research
- Ad libitum Weekend Recovery Sleep Fails to Prevent Metabolic Dysregulation during a Repeating Pattern of Insufficient Sleep and Weekend Recovery Sleep
- (2019) Christopher M. Depner et al. CURRENT BIOLOGY
- The Mediterranean Diet and Cardiovascular Health
- (2019) Miguel A. Martínez-González et al. CIRCULATION RESEARCH
- Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report
- (2019) Alison B. Evert et al. DIABETES CARE
- Implementation of Basal–Bolus Therapy in Type 2 Diabetes: A Randomized Controlled Trial Comparing Bolus Insulin Delivery Using an Insulin Patch with an Insulin Pen
- (2019) Richard M. Bergenstal et al. Diabetes Technology & Therapeutics
- Resurgence in Diabetes-Related Complications
- (2019) Edward W. Gregg et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
- (2019) Vlado Perkovic et al. NEW ENGLAND JOURNAL OF MEDICINE
- Team-Based Care to Improve Diabetes Management: A Community Guide Meta-analysis
- (2019) Timothy W. Levengood et al. AMERICAN JOURNAL OF PREVENTIVE MEDICINE
- Physical activity, multimorbidity, and life expectancy: a UK Biobank longitudinal study
- (2019) Yogini V. Chudasama et al. BMC Medicine
- Lack of Durable Improvements in β-Cell Function Following Withdrawal of Pharmacological Interventions in Adults With Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes
- (2019) DIABETES CARE
- Do GLP‐1RA and SGLT‐2i reduce cardiovascular events in black patients with type 2 diabetes? A systematic review and meta‐analysis
- (2019) Basem M Mishriky et al. DIABETES OBESITY & METABOLISM
- Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
- (2019) Hertzel C Gerstein et al. LANCET
- Switching to iGlarLixi Versus Continuing Daily or Weekly GLP-1 RA in Type 2 Diabetes Inadequately Controlled by GLP-1 RA and Oral Antihyperglycemic Therapy: The LixiLan-G Randomized Clinical Trial
- (2019) Lawrence Blonde et al. DIABETES CARE
- Impact of technology on glycaemic control in type 2 diabetes: A meta‐analysis of randomized trials on continuous glucose monitoring and continuous subcutaneous insulin infusion
- (2019) Ilaria Dicembrini et al. DIABETES OBESITY & METABOLISM
- Effects of sodium‐glucose co‐transporter‐2 inhibitors in type 2 diabetes in women versus men
- (2019) Karin Rådholm et al. DIABETES OBESITY & METABOLISM
- Effect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes
- (2019) Julio Rosenstock et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Glycaemic durability of an early combination therapy with vildagliptin and metformin versus sequential metformin monotherapy in newly diagnosed type 2 diabetes (VERIFY): a 5-year, multicentre, randomised, double-blind trial
- (2019) David R Matthews et al. LANCET
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Creating a Learning Health System through Rapid-Cycle, Randomized Testing
- (2019) Leora I. Horwitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sodium-glucose cotransporter 2 (SGLT-2) inhibitors and microvascular outcomes in patients with type 2 diabetes: systematic review and meta-analysis
- (2019) E. G. Dorsey-Treviño et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Durability of insulin degludec plus liraglutide versus insulin glargine U100 as initial injectable therapy in type 2 diabetes (DUAL VIII): a multicentre, open-label, phase 3b, randomised controlled trial
- (2019) Vanita R Aroda et al. Lancet Diabetes & Endocrinology
- SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis
- (2019) Brendon L Neuen et al. Lancet Diabetes & Endocrinology
- Effects of exenatide and open-label SGLT2 inhibitor treatment, given in parallel or sequentially, on mortality and cardiovascular and renal outcomes in type 2 diabetes: insights from the EXSCEL trial
- (2019) Lindsay E. Clegg et al. Cardiovascular Diabetology
- GRADE guidelines 26: informative statements to communicate the findings of systematic reviews of interventions
- (2019) Nancy Santesso et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- The Impact of Flash Glucose Monitoring on Glycaemic Control as Measured by HbA1c: A Meta-analysis of Clinical Trials and Real-World Observational Studies
- (2019) Mark Evans et al. Diabetes Therapy
- 2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2019) John B. Buse et al. DIABETOLOGIA
- Prevalence of Prediabetes Among Adolescents and Young Adults in the United States, 2005-2016
- (2019) Linda J. Andes et al. JAMA Pediatrics
- Rapid-Acting Insulin Analogues Versus Regular Human Insulin: A Meta-Analysis of Effects on Glycemic Control in Patients with Diabetes
- (2019) Antonio Nicolucci et al. Diabetes Therapy
- Effects of low-carbohydrate- compared with low-fat-diet interventions on metabolic control in people with type 2 diabetes: a systematic review including GRADE assessments
- (2018) Esther J van Zuuren et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Comparative Benefits and Harms of Basal Insulin Analogues for Type 2 Diabetes
- (2018) Anastasia-Vasiliki Madenidou et al. ANNALS OF INTERNAL MEDICINE
- Sex Differences in the Burden and Complications of Diabetes
- (2018) Sanne A. E. Peters et al. Current Diabetes Reports
- A1C Targets Should Be Personalized to Maximize Benefits While Limiting Risks
- (2018) Matthew C. Riddle et al. DIABETES CARE
- Impact of Insulin and Metformin Versus Metformin Alone on β-Cell Function in Youth With Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes
- (2018) DIABETES CARE
- Metformin Treatment in Patients With Type 2 Diabetes and Chronic Kidney Disease Stages 3A, 3B, or 4
- (2018) Jean-Daniel Lalau et al. DIABETES CARE
- Comparison of glucose-lowering agents after dual therapy failure in type 2 diabetes: A systematic review and network meta-analysis of randomized controlled trials
- (2018) Francesco Zaccardi et al. DIABETES OBESITY & METABOLISM
- Free and fixed-ratio combinations of basal insulin and GLP-1 receptor agonists versus basal insulin intensification in type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials
- (2018) Maria Ida Maiorino et al. DIABETES OBESITY & METABOLISM
- Semaglutide, reduction in glycated haemoglobin and the risk of diabetic retinopathy
- (2018) Tina Vilsbøll et al. DIABETES OBESITY & METABOLISM
- SGLT2 inhibitor plus DPP-4 inhibitor as combination therapy for type 2 diabetes: A systematic review and meta-analysis
- (2018) Dandan Li et al. DIABETES OBESITY & METABOLISM
- Effect of dietary carbohydrate restriction on glycemic control in adults with diabetes: A systematic review and meta-analysis
- (2018) Emma Sainsbury et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Intermittent fasting in Type 2 diabetes mellitus and the risk of hypoglycaemia: a randomized controlled trial
- (2018) B. T. Corley et al. DIABETIC MEDICINE
- A network meta-analysis on the comparative efficacy of different dietary approaches on glycaemic control in patients with type 2 diabetes mellitus
- (2018) Lukas Schwingshackl et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- The effect of nurse prescribers on glycaemic control in type 2 diabetes: A systematic review and meta -analysis
- (2018) Maryam Tabesh et al. INTERNATIONAL JOURNAL OF NURSING STUDIES
- Long-term treatment with metformin in type 2 diabetes and methylmalonic acid: Post hoc analysis of a randomized controlled 4.3 year trial
- (2018) Mattijs Out et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- A Randomized Controlled Study Comparing a DPP4 Inhibitor (Linagliptin) and Basal Insulin (Glargine) in Patients With Type 2 Diabetes in Long-term Care and Skilled Nursing Facilities: Linagliptin-LTC Trial
- (2018) Guillermo E. Umpierrez et al. Journal of the American Medical Directors Association
- Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial
- (2018) Michael EJ Lean et al. LANCET
- Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts
- (2018) Ramón Estruch et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of nutrition therapy on HbA1c and cardiovascular disease risk factors in overweight and obese patients with type 2 diabetes
- (2018) Adham Mottalib et al. Nutrition Journal
- The Effects of Postprandial Exercise on Glucose Control in Individuals with Type 2 Diabetes: A Systematic Review
- (2018) Andrew Borror et al. SPORTS MEDICINE
- Combination of sodium-glucose cotransporter 2 inhibitor and dipeptidyl peptidase-4 inhibitor in type 2 diabetes: a systematic review with meta-analysis
- (2018) Se Hee Min et al. Scientific Reports
- Rethinking the Viability and Utility of Inhaled Insulin in Clinical Practice
- (2018) Lutz Heinemann et al. Journal of Diabetes Research
- Do sulphonylureas still have a place in clinical practice?
- (2018) Kamlesh Khunti et al. Lancet Diabetes & Endocrinology
- Diabetes structured self-management education programmes: a narrative review and current innovations
- (2018) Sudesna Chatterjee et al. Lancet Diabetes & Endocrinology
- Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables
- (2018) Emma Ahlqvist et al. Lancet Diabetes & Endocrinology
- Association of Time in Range, as Assessed by Continuous Glucose Monitoring, With Diabetic Retinopathy in Type 2 Diabetes
- (2018) Jingyi Lu et al. DIABETES CARE
- Exercise training modalities in patients with type 2 diabetes mellitus: a systematic review and network meta-analysis
- (2018) Bei Pan et al. International Journal of Behavioral Nutrition and Physical Activity
- Efficacy and Safety of Initial Combination Therapy in Treatment-Naïve Type 2 Diabetes Patients: A Systematic Review and Meta-analysis
- (2018) Xiaoling Cai et al. Diabetes Therapy
- GLP-1 receptor agonist added to insulin versus basal-plus or basal-bolus insulin therapy in type 2 diabetes: A systematic review and meta-analysis
- (2018) Marco Castellana et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2018) Melanie J. Davies et al. DIABETOLOGIA
- Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk
- (2018) Julio Rosenstock et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
- (2018) Stephen D. Wiviott et al. NEW ENGLAND JOURNAL OF MEDICINE
- Outcomes of Bariatric Surgery Versus Medical Management for Type 2 Diabetes Mellitus: a Meta-Analysis of Randomized Controlled Trials
- (2018) Zhamak Khorgami et al. OBESITY SURGERY
- Supported self-management for people with type 2 diabetes: a meta-review of quantitative systematic reviews
- (2018) Mireille Captieux et al. BMJ Open
- Physical Function Following a Long-Term Lifestyle Intervention Among Middle Aged and Older Adults With Type 2 Diabetes: The Look AHEAD Study
- (2017) Denise K Houston et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes
- (2017) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- The impact of sleep amount and sleep quality on glycemic control in type 2 diabetes: A systematic review and meta-analysis
- (2017) Shaun Wen Huey Lee et al. SLEEP MEDICINE REVIEWS
- Supporting insulin initiation in type 2 diabetes in primary care: results of the Stepping Up pragmatic cluster randomised controlled clinical trial
- (2017) John Furler et al. BMJ-British Medical Journal
- Clinical inertia—Time to reappraise the terminology?
- (2017) Kamlesh Khunti et al. Primary Care Diabetes
- Overcoming clinical inertia in insulin initiation in primary care for patients with type 2 diabetes: 24-month follow-up of the Stepping Up cluster randomised controlled trial
- (2017) Jo-Anne Manski-Nankervis et al. Primary Care Diabetes
- Supporting insulin initiation in type 2 diabetes in primary care: results of the Stepping Up pragmatic cluster randomised controlled clinical trial
- (2017) John Furler et al. BMJ-British Medical Journal
- Thiazolidinediones and Advanced Liver Fibrosis in Nonalcoholic Steatohepatitis
- (2017) Giovanni Musso et al. JAMA Internal Medicine
- Glucose Self-monitoring in Non–Insulin-Treated Patients With Type 2 Diabetes in Primary Care Settings
- (2017) Laura A. Young et al. JAMA Internal Medicine
- Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial
- (2017) Olga Vaccaro et al. Lancet Diabetes & Endocrinology
- What Is Shared Decision Making? (and What It Is Not)
- (2016) Marleen Kunneman et al. ACADEMIC EMERGENCY MEDICINE
- Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus
- (2016) Kenneth Cusi et al. ANNALS OF INTERNAL MEDICINE
- Safety and Tolerability of Glucagon-Like Peptide-1 Receptor Agonists Utilizing Data from the Exenatide Clinical Trial Development Program
- (2016) Hui Peng et al. Current Diabetes Reports
- Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations
- (2016) Francesco Rubino et al. DIABETES CARE
- Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial
- (2016) Vanita R. Aroda et al. DIABETES CARE
- Psychosocial Care for People With Diabetes: A Position Statement of the American Diabetes Association
- (2016) Deborah Young-Hyman et al. DIABETES CARE
- Benefits for Type 2 Diabetes of Interrupting Prolonged Sitting With Brief Bouts of Light Walking or Simple Resistance Activities
- (2016) Paddy C. Dempsey et al. DIABETES CARE
- Triple therapy combinations for the treatment of type 2 diabetes – A network meta-analysis
- (2016) Crystal Man Ying Lee et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Effect of Insulin Glargine Up-titration vs Insulin Degludec/Liraglutide on Glycated Hemoglobin Levels in Patients With Uncontrolled Type 2 Diabetes
- (2016) Ildiko Lingvay et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Theory-based self-management educational interventions on patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials
- (2016) Fang-Fang Zhao et al. JOURNAL OF ADVANCED NURSING
- Pioglitazone and Risk for Bone Fracture: Safety Data from a Randomized Clinical Trial
- (2016) Catherine M. Viscoli et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study
- (2016) Vanita R. Aroda et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Pioglitazone after Ischemic Stroke or Transient Ischemic Attack
- (2016) Walter N. Kernan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized controlled trial of a nationally available weight control program tailored for adults with type 2 diabetes
- (2016) Patrick M. O'Neil et al. Obesity
- Diabetes self-management education for adults with type 2 diabetes mellitus: A systematic review of the effect on glycemic control
- (2016) Carole A. Chrvala et al. PATIENT EDUCATION AND COUNSELING
- Medication adherence in patients with diabetes mellitus: does physician drug dispensing enhance quality of care? Evidence from a large health claims database in Switzerland
- (2016) Carola A Huber et al. Patient Preference and Adherence
- Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors
- (2016) William Polonsky et al. Patient Preference and Adherence
- A randomized clinical trial evaluating the safety and efficacy of sitagliptin added to the combination of sulfonylurea and metformin in patients with type 2 diabetes mellitus and inadequate glycemic control
- (2016) Robert G. Moses et al. Journal of Diabetes
- Lower rates of hypoglycemia during maintenance treatment with insulin degludec/insulin aspart versus biphasic insulin aspart 30: a combined analysis of two Phase 3a studies in type 2 diabetes
- (2016) Jens Sandahl Christiansen et al. Journal of Diabetes
- Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial
- (2016) Lancet Diabetes & Endocrinology
- Shared decision making in endocrinology: present and future directions
- (2016) Rene Rodriguez-Gutierrez et al. Lancet Diabetes & Endocrinology
- Microvascular disease and risk of cardiovascular events among individuals with type 2 diabetes: a population-level cohort study
- (2016) Jack R W Brownrigg et al. Lancet Diabetes & Endocrinology
- The Efficacy of IDegLira (Insulin Degludec/Liraglutide Combination) in Adults with Type 2 Diabetes Inadequately Controlled with a GLP-1 Receptor Agonist and Oral Therapy: DUAL III Randomized Clinical Trial
- (2016) Sultan Linjawi et al. Diabetes Therapy
- The Efficacy of IDegLira (Insulin Degludec/Liraglutide Combination) in Adults with Type 2 Diabetes Inadequately Controlled with a GLP-1 Receptor Agonist and Oral Therapy: DUAL III Randomized Clinical Trial
- (2016) Sultan Linjawi et al. Diabetes Therapy
- Behavioral Programs for Type 2 Diabetes Mellitus
- (2015) Jennifer Pillay et al. ANNALS OF INTERNAL MEDICINE
- The changing face of diabetes in youth: lessons learned from studies of type 2 diabetes
- (2015) Tamara S. Hannon et al. Annals of the New York Academy of Sciences
- Sex Differences in the Cardiovascular Consequences of Diabetes Mellitus
- (2015) Judith G. Regensteiner et al. CIRCULATION
- Meta-analysis of studies examining medication adherence, persistence, and discontinuation of oral antihyperglycemic agents in type 2 diabetes
- (2015) Kristy Iglay et al. CURRENT MEDICAL RESEARCH AND OPINION
- Comparison of vildagliptin as an add-on therapy and sulfonylurea dose-increasing therapy in patients with inadequately controlled type 2 diabetes using metformin and sulfonylurea (VISUAL study): A randomized trial
- (2015) A Ram Hong et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Efficacy and safety of antihyperglycaemic drug regimens added to metformin and sulphonylurea therapy in Type 2 diabetes: a network meta-analysis
- (2015) E. S. Mearns et al. DIABETIC MEDICINE
- Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
- (2015) Silvio E. Inzucchi et al. DIABETOLOGIA
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Triple therapy in type 2 diabetes; a systematic review and network meta-analysis
- (2015) Martin J. Downes et al. PeerJ
- Longitudinal Effects of Medication Nonadherence on Glycemic Control
- (2014) Leonard E. Egede et al. ANNALS OF PHARMACOTHERAPY
- Contribution of Liraglutide in the Fixed-Ratio Combination of Insulin Degludec and Liraglutide (IDegLira)
- (2014) John B. Buse et al. DIABETES CARE
- Diabetes as risk factor for incident coronary heart disease in women compared with men: a systematic review and meta-analysis of 64 cohorts including 858,507 individuals and 28,203 coronary events
- (2014) Sanne A. E. Peters et al. DIABETOLOGIA
- How to Use a Subgroup Analysis
- (2014) Xin Sun et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Magnitude of Cognitive Dysfunction in Adults with Type 2 Diabetes: A Meta-analysis of Six Cognitive Domains and the Most Frequently Reported Neuropsychological Tests Within Domains
- (2014) Priya Palta et al. JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY
- Glucagon-like peptide-1 receptor agonist and basal insulin combination treatment for the management of type 2 diabetes: a systematic review and meta-analysis
- (2014) Conrad Eng et al. LANCET
- Diabetes as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 64 cohorts, including 775 385 individuals and 12 539 strokes
- (2014) Sanne A E Peters et al. LANCET
- Effects of Metformin, Metformin Plus Rosiglitazone, and Metformin Plus Lifestyle on Insulin Sensitivity and -Cell Function in TODAY
- (2013) DIABETES CARE
- A randomized controlled trial of the efficacy and safety of saxagliptin as add-on therapy in patients with type 2 diabetes and inadequate glycaemic control on metformin plus a sulphonylurea
- (2013) R. G. Moses et al. DIABETES OBESITY & METABOLISM
- Efficacy and safety of vildagliptin in patients with type 2 diabetes mellitus inadequately controlled with dual combination of metformin and sulphonylurea
- (2013) V. Lukashevich et al. DIABETES OBESITY & METABOLISM
- GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations
- (2013) Jeff Andrews et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): a cohort analysis
- (2013) Thomas Yates et al. LANCET
- Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2012) S. E. Inzucchi et al. DIABETOLOGIA
- Basal Insulin and Cardiovascular and Other Outcomes in Dysglycemia
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- The Diabetes Mellitus Medication Choice Decision Aid
- (2009) Rebecca J. Mullan et al. ARCHIVES OF INTERNAL MEDICINE
- Cardiovascular risk assessment scores for people with diabetes: a systematic review
- (2009) P. Chamnan et al. DIABETOLOGIA
- Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial
- (2009) Philip D Home et al. LANCET
- Rosiglitazone-Associated Fractures in Type 2 Diabetes: An analysis from A Diabetes Outcome Progression Trial (ADOPT)
- (2008) S. E. Kahn et al. DIABETES CARE
- The design of a decision aid about diabetes medications for use during the consultation with patients with type 2 diabetes
- (2008) Maggie Breslin et al. PATIENT EDUCATION AND COUNSELING
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now